Ketamine is an uncompetitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist. It induces effects in healthy individuals that mimic symptoms associated with schizophrenia. We sought to root these experiences in altered brain function, specifically aberrant resting state functional connectivity (rsfMRI). In the present study, we acquired rsfMRI data under ketamine and placebo in a between-subjects design and analyzed seed-based measures of rsfMRI using large-scale networks, dorsolateral prefrontal cortex (DLPFC) and sub-nuclei of the thalamus. We found ketamine-induced alterations in rsfMRI connectivity similar to those seen in patients with schizophrenia, some changes that may be more comparable to early stages of schizophrenia, and other connectivity signatures seen in patients that ketamine did not recreate.
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Introduction
Ketamine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist used in healthy volunteers as a safe, transient model of the symptoms of schizophrenia (Krystal et al, 1994; Krystal et al, 2003) . Ketamine induces delusion-like ideas, thought disorder, tangential speech, negative symptoms, working memory (WM) deficits, and illusory percepts (Corlett et al, 2007a; Driesen et al, 2013a; . Similarities between the neural effects of ketamine and findings in schizophrenia (reviewed in: Haaf et al, 2018 & Frohlich and Van Horn, 2013) have also supported ketamine's use in modeling these symptoms (Krystal et al, 2003; Krystal et al, 2017) . This work has implicated perturbed NMDA receptor function and glutamate transmission in the pathophysiology of schizophrenia (Balu, 2016) . Interestingly, ketamine has also been shown to have affects on mood symptoms and act as a rapid-acting antidepressant, which is not relevant to its use as a model of schizophrenia but could be relevant to some of the changes in brain connectivity previous reported under ketamine.
There is a vastly expanding literature on changes in functional connectivity (fc) observed in patients with schizophrenia, particularly during resting state (Driesen et al, 2013b; Anticevic et al, 2014a; Anticevic et al, 2014b; Lefort-Besnard et al, 2017; Zhou et al, 2017) . It would be useful to determine which biomarkers associated with schizophrenia are also present following ketamine infusions, and whether these correlate with various psychotic symptoms specifically. This is important for making inferences about the relationships between NMDA dysfunction, fc changes, and symptoms of schizophrenia. We assessed changes in fc in participants given relatively high doses of ketamine compared to saline infusion during rest. We focused on those changes highlighted by meta-analyses of resting fc in schizophrenia (Sheffield and Barch, 2016; Li et al, 2017) Zhou et al, 2017; Ferri et al, 2018) . Others have recently studied the effects of ketamine on connectivity with some of these regions at sub-anesthetic (Mueller et al, 2018) and various anesthetic (Bonhomme et al, 2016) doses. However, we were particularly interested in the relationships of these functional connectivity changes with psychotic symptoms, so we used higher sub-anasthetic doses of ketamine and a greater number of participants administered ketamine in order to assess these symptom correlations.
First, we assayed fc of the default-mode network (DMN), particularly with regions within "task-positive networks" including the dorsal attention network (DAN) and fronto-parietal control network (FPN). The default mode network is generally more active during "rest" scans or social cognition tasks, whereas these task positive networks (TPN) are generally more active during tasks such as those involving working memory than rest (reviewed in Raichle, 2015) . Therefore these networks have an anti-correlated relationship with each other. A decrease in this standard anti-correlation between the DMN and the FPN has been observed in patients with schizophrenia during both rest and a WM task, and this correlated with WM performance and positive symptoms (Whitfield-Gabrieli et al, 2009 ). This has also been shown in participants given ketamine during a WM task . Similarly, disruptions in fc between the DMN and DAN have been observed in patients with schizophrenia during rest (Lefort-Besnard et al, 2017 ) and during a WM task (Zhou et al, 2017) , although the directions of change varied across sub-regions of these networks at rest (Lefort-Besnard et al, 2017) . We conducted seed-based analyses using the average time series of all of the combined regions within each of these networks in order to determine whether large-scale network dynamics were altered by ketamine at rest. Unlike previous work using a representative seed within each network (Mueller et al, 2018) , we wanted to explore the interactions between these networks as a whole. Our results also led us
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to follow up with a specific analysis of the differences in connectivity, under ketamine versus saline, between the "salience network" (SAL) and the DAN, FPN and DMN. The salience network has been shown to mediate the anti-correlation between task positive networks and the DMN (Chen et al, 2013; Zhou et al, 2018) .
Next, we assessed the effects of ketamine on connectivity between the right DLPFC and other voxels in the brain compared to saline. The DLPFC is a region within the FPN that has consistently been implicated in working memory deficits in schizophrenia Driesen et al, 2013b; Corlett et al, 2006; Whitfield-Gabrieli et al, 2009) , as well as prediction error deficits and delusions in psychosis for the right DLPFC specifically (Corlett et al, 2006; Corlett et al, 2007b) . Similarly, participants given ketamine show working memory deficits and coinciding alterations in DLPFC connectivity during WM tasks (Driesen et al, 2013a) .
NMDA dysfunction may therefore play a role in the DLPFC dysconnectivity and WM impairment in schizophrenia. Additionally, in patients with schizophrenia, the strongest shift in the anti-correlation of task positive regions with seeds of the DMN has been observed in the right DLPFC during rest (Whitfield-Gabrieli et al, 2009 ). This has inspired others to explore alterations in DLPFC fc under ketamine during rest as a representation of task-positive network connectivity changes (Mueller et al, 2018) . Our combination of the FPN network and a more targeted right DLPFC-based analysis could identify region-specific trends in addition to the large-scale network dynamics under ketamine during rest in the same group of participants.
We also examined the effect of ketamine versus saline on connectivity between two nuclei within the thalamus and the rest of the brain. In patients with schizophrenia, alterations in the connectivity between the thalamus and sensory-motor cortices, as well as prefrontal, striatal and cerebellar regions have been reported (Anticevic et al, 2014a; Li et al, 2017; Ferri et al, 2018) ,
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and shown to correlate with positive symptoms (Ferri et al, 2018) . These effects were shown to be localized to two nuclei of the thalamus that are heavily connected with the PFC and primary visual cortex: the medio-dorsal (MD) nucleus and lateral geniculate nucleus (LGN) (Anticevic et al, 2014a) . Using the MD nucleus and the LGN as seeds, Anticevic and colleagues (2014a) showed that both of these nuclei have uniquely altered connectivity patterns in patients with schizophrenia compared to controls. Additionally, the MD thalamus in particular has wellestablished structural abnormalities in patients with schizophrenia, which have not been observed in the LGN (reviewed in Pergola et al, 2015) . And changes in a BOLD fMRI measure of blood flow in the left medial region of the thalamus under high doses of ketamine correlate positively with perceptual distortion symptoms of psychosis (Pollak et al, 2015) . Changes in the LGN have been observed in schizoaffective and mood disorder patients, so connectivity with this region of thalamus may play a role in negative mood symptoms not usually observed under ketamine (Dorph-Petersen et al, 2008; reviewed in Leivada and Boeckx, 2014) . We sought to assess whether NMDA blockade induces connectivity changes in the LGN and MD thalamus in a way that potentially correlates with psychotic symptoms.
Materials and methods:
Subjects
Fifty-three subjects (previously reported in Javitt et al, 2018) , recruited from three academic research institutions, were medically healthy men and women aged 18 to 55 years old (mean(SD)=31.1(9.6)) without current or past Axis I or II psychiatric or substance history.
Exclusion criteria included: a history of recreational use of ketamine, PCP or other NMDAR modulators; adverse reaction to therapeutic ketamine; first-degree relative with schizophrenia; clinically significant history of violence or suicidality; history of significant medical illness,
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including high blood pressure (>140/90); significant neurological illness or head injury; pregnancy; current psychotropic medication use; or color blindness.
Design
The study was approved by the Local Research Ethics Committees at Yale, Columbia and UC Davis. All subjects gave written informed consent prior to enrollment. Subjects were randomized to ketamine or placebo groups in a 2:1 ratio. More participants were included in the ketamine group in order to increase the range of symptoms for the critical symptom correlation analyses. Subjects participated in two MRI sessions; here we report the results from the resting state fMRI study on infusion day two. Other data for MRS and BOLD task-relevant activation were reported elsewhere (Javitt et al, 2018) . The resting scans were acquired 10-min pre and post-ketamine or saline bolus. Clinical assessments were performed following the end of the onehour infusion. Subjects and clinical researchers were blinded to treatment group. Treatment assignment was randomized and stratified by site so as to minimize site confounds. Demographic information and symptoms induced by ketamine are broken down across site (Table 1) . Scores and ketamine concentrations also included as mean (standard deviation) values for all subjects receiving ketamine (left) and saline (right) across all three sites. There were significant drug condition by site interaction effects for BPRS-Negative (p=.021), and CADSS-Percept (p=.021) and a main effect of site for CADSS-Percept (.011).
There was also a trending difference across sites for ketamine blood levels (p=.073) but not for nor-ketamine levels Moreover, the paradigm sought to achieve ketamine plasma levels of ~150 ng/mL (Shaffer et al, 2014) , associated with moderately high psychotomimetic responses (D'Souza et al, 2012) in the relative absence of sedation, agitation, or other problematic effects. Ketamine and nor-ketamine levels were measured for all subjects given ketamine, except three from Columbia for technical reasons.
Clinical and safety measures
Subjects were rated with the Brief Psychiatric Rating Scale (BPRS), Profile of Mood States (POMS), and Clinician Administered Dissociative Symptom Scale (CADSS) (Krystal et al, 1994) . Sub-scores for positive and negative symptoms were extracted from the BPRS, as well as a "Perception" sub-score from the CADSS (which captures aberrant salience experiences). These were used to analyze the relationship between changes in connectivity and symptoms.
Scanning parameters
All fMRI scans were conducted on 3T scanners at Yale University, Columbia University, or University of California at Davis on the following scanners respectively: 3T Siemens TIM TRIO, 3T GE MR750, and 3T Siemens TIM TRIO. All sites used a 32-channel head coil. The same scanning parameters were used across all sites (detailed scanner specifications can be found in Javitt et al, 2018) . Briefly, before initial resting state scans, high-resolution T1*weighted anatomical images were acquired for image registration (TR=1900 ms, TE=2.98ms, TI=1100ms,
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). Then for both pre-drug baseline and post-drug functional imaging, 32 axial-oblique slices were obtained in an interleaved pattern (TR=200ms, TE=30 .0ms, FOV=220mm, matrix=64*64, slice thickness=4.0mm, one voxel=3.4x3.4x4.0mm).
Image processing
Images were pre-processed in MNI space and functional connectivity was analyzed in Volumes in which the normalized z-scores from global mean signal intensity exceeded 9 or the framewise composite displacement was over 2mm in x, y or z translations or 0.9 degrees in the pitch, roll or yaw rotations were identified as outliers. These outlier time points, likely caused by head motion, were then regressed out as nuisance covariates and analyses were conducted to determine whether there were differences in various motion parameters across the drug conditions (Table 2) validated as effective in identifying meaningful anti-correlations in resting-state data (Chai et al, 2013) . After white matter, CSF, and realignment/motion outlier confounds were removed, BOLD signal de-spiking was performed using a continuous hyperbolic tangent squashing function in the toolbox to further reduce the influence of outlier scans. Next, images were band-pass filtered using SPM-based Fast Fourier Transformation (FFT) methods (0.0078-0.1Hz). All EPI-BOLD images were registered to the high-resolution T1*weighted structural images, and then to MNI space. Finally, a 6mm full-width half-maximum (FWHM) Gaussian kernel was used for smoothing. All correlation coefficients were converted to normally distributed z-scores for firstlevel analyses to allow for second-level GLM analyses.
Large-scale networks
The large-scale network analyses were conducted between DMN, DAN, FPN and the atlas provided in CONN to parcellate the whole brain into functional sub-regions. (Benjamini and Hochberg, 1995) .
Our follow-up analysis with the salience network also used the combined sub-regions of
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DLPFC
The right DLPFC was set as a seed region, and correlations were calculated between this seed and all other voxels in the brain. The coordinates of the 10mm sphere for this seed are listed in Supplemental Table 1 . A voxel-level height threshold of p<0.001 was applied to these analyses, and then the resulting supra-threshold clusters were reported as significant only with cluster-level false discovery rate (FDR)-corrected p-values less than 0.05 (Benjamini and Hochberg, 1995) .
Thalamic Nuclei
For the seed-to-voxel analyses of thalamic nuclei, masks were created in SPM Anatomy
Toolbox (Eickhoff et al, 2005) using the "visual thalamus" and "MD thalamus" seeds based on functional mapping of the thalamus from Behrens and colleagues (2003) . Correlations between these seed regions and all other voxels were calculated. The same thresholding procedure was used for this analysis as the DLPFC.
Statistical analysis
Two sample t-tests were used to assess differences in demographics (sex, race, age) across treatment groups. To ensure our effects were not driven by motion, t-test were used to detect differences across drug groups in average and maximum motion realignment parameters
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A C C E P T E D M A N U S C R I P T (Table 2 ). Next, one-way ANOVAs were used to assess the difference in clinical measures across site and drug condition (BPRS, CADSS, POMS) using change in score measures (post-infusion minus pre-infusion) with FDR corrections applied. All connectivity analyses involved t-tests on the difference (post-drug minus pre-drug) in z-scored correlations across brain regions between participants given saline versus ketamine. The scanning site was always entered as a covariate in each of these analyses. Effect sizes in the form of standardized beta values are reported, representing the average difference in Fishertransformed correlation coefficients between drug groups.
Symptom Correlations
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All symptom correlations were conducted between symptoms scores of subjects given ketamine and connectivity values across our various regions of interest. Symptom score correlations for the large-scale network analyses were conducted in R Studio (http://www.rstudio.com/). We removed outliers 2 standard deviations from the mean and conducted Spearman rank partial correlations controlling for site with nonparametric permutation tests for significance testing using 10,000 permutations (using the RVAideMemoire package in R; Hervé, 2015) . Because of our particular interest in psychotic symptoms, we limited our largescale network symptom analyses to connectivity between regions previous literature has suggested might be important in positive symptoms of psychosis (Manoliu et al, 2013; Pollak et al, 2015; Raji et al, 2015) . This included connectivity of the DMN with DAN and FPN, as well as our large-scale network connectivity with the putamen and thalamus, which also seem to have important functional connections for regulating DMN and task-positive network dynamics (Di and Biswal, 2014) . Then FDR-correction was applied to p-values, and only p(FDR)<.05 was reported.
For the DLPFC and thalamic-seed symptom correlation analyses, we did partial correlations in subjects given ketamine, controlling for site with nonparametric, permutation tests with 1000 iterations. A voxel-level height threshold of p<.001 was applied to the whole brain and then results of cluster-level p(FDR)<.05 were reported.
Results
Sample
Subjects showed no group differences for average age (p(FDR)=0.70) or gender distribution (p(FDR)=0.18) based on drug assignment (34 ketamine/19 placebo). No serious or unexpected adverse events were reported in the study. Ketamine levels were on average
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A C C E P T E D M A N U S C R I P T 110ng/mL, which was significantly lower than the target 150 ng/mL blood concentration (p(FDR)<.001; blood levels reported across sites in Table 1 ).
Clinical ratings
CADSS, BPRS and POMS scores were greater under ketamine compared to saline (main effect of drug condition: p(FDR)=0.006, 0.03 and 0.019). The BPRS positive (p(FDR)=0.0001), BPRS-negative (p(FDR)=0.010 and CADSS-perceptual (p(FDR)=0.0002) subscales also showed significant changes across ketamine and saline participants.
Covariates
There were no differences in average (p(FDR)=0.564) nor maximum (p(FDR)=0.33) head motion between the drug conditions. There also were no significant gender differences for any connectivity measure of interest in our analyses (p(FDR)>0.33). Our analyses for differences in connectivity across the three sites revealed no effect of site for DLPFC, LGN, or any of the large-scale networks. However, the connectivity between MD thalamus and a cluster of voxels in superior temporal cortex did show a significant effect of site (coordinates: 52, -46, 14; 115 voxels; p(FDR)=.0281). This region overlapped with a region that showed significant differences across saline and ketamine (see below) however the effect of ketamine survived when controlling for site in these analyses. There were differences in symptoms evinced by the ketamine treatment across sites (see Table 1 ), which could possibly be related to a trending difference in ketamine concentrations (p=.073) (but not nor-ketamine concentration (p=.88)) across site. This is why site was included as a covariate in our imaging as well as symptom correlation analyses.
Large-scale network connectivity
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In our DMN/DAN/FPN large-scale network analyses, we did not find any effect of ketamine compared to saline on DMN-DAN connectivity (p(FDR)=0.980) or DMN-FPN connectivity (p(FDR)=0.0742). However, ketamine increased the correlation between the DMN and a range of regions across the cortex and striatum compared to saline (Table 3) including the anterior cingulate cortex (ACC) (Figure 1a ), posterior cingulate cortex (PCC) (Figure 1b ), left nucleus accumbens (Figure 1c ), bilateral insula (Figure 1d and 1e) , right paracingulate gyrus ( Figure 1f ) and right frontal pole (Figure 1g ). Our results showed changes between the large-scale networks and regions of the salience
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network, which has previously been implicated as important for modulating the relationship between task positive and default mode networks (Chen et al, 2013; Zhou et al, 2018) and dysfunction in this relationship has been implicated in schizophrenia (Manoliu et al, 2014; Wortruba et al, 2014) . Therefore, we followed up with a direct analysis of the differences in connectivity between the salience network and our default mode and task positive networks. Our findings showed that connectivity between the salience network and whole DMN seed was increased under ketamine, at least in part driven by significant differences in the right lateral parietal seed in the DMN (Table 3 ; Figure 2 ). There were also increases in salience network connectivity with regions of the FPN, including right posterior parietal cortex and left prefrontal cortex under ketamine (Table 3 ; Figure 2 ). 
Figure 2. Altered connectivity between SAL and subregions of the FPN and DMN in participants
DLPFC connectivity
When looking more closely at the dorsolateral PFC within the FPN, we found that connectivity with the DLPFC was disrupted by ketamine in a cluster of voxels in the right postcentral gyrus and in the pons (Figure 3 ; Table 3 ). None of the regions differentially connected with DLPFC under ketamine were part of the DMN or DAN. 
Thalamic nuclei connectivity
Our analyses with the two sub-nuclei of the thalamus (LGN and MD, which exhibit aberrant connectivity in schizophrenia (Anticevic et al, 2014a) ), revealed that the MD thalamus evinced increased connectivity with the right superior temporal gyrus in participants given ketamine versus saline (Table 3 ; Figure 4) . Part of the right parahippocampal gyrus also showed increased connectivity with the MD nucleus under ketamine. But no differences were found
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between the saline and ketamine groups for the connectivity between the LGN seed and any other voxels in the brain. Color bar represents t-value; p(FDR)<.05
Symptom Correlations
Large-scale networks
Given our interest in ketamine's use as a tool to elicit symptoms of psychosis, we investigated how functional connectivity between our network ROIs and regions of thalamus and striatum under ketamine correlated with positive symptom ratings. None of the regions of interest we selected showed a significant relationship with positive symptoms induced under ketamine (p(FDR)>0.35).
DLPFC-seed
POMS mood scores correlated with DLPFC connectivity with ACC as well as a region of left frontal orbital cortex connectivity (Table 3) .
Thalamic seeds
Functional connectivity with the MD nucleus of the thalamus did not correlate with any symptom scores in participants given ketamine.
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Large-scale networks:
DMN-ACC -- -- -- -- K
Discussion
Our results did not reveal an effect of ketamine compared to saline on DMN-FPN or DMN-DAN connectivity during rest, an effect previously shown in patients with schizophrenia (Whitfield-Gabrieli et al, 2009; Gerretsen et al, 2014) and in participants given ketamine during a WM task . Mueller and colleagues (2018) similarly found no change in DLPFC connectivity with regions of DMN with a lower dose of ketamine at rest. Although, a dose of ketamine that achieved blood levels over six times those observed in this study did find altered DMN-TPN connectivity (Bonhomme et al, 2016) , so it is possible these large-scale network effects are dose-dependent.
In our study, connectivity between the DMN and ACC, insula, PCC, nucleus accumbens, paracingulate cortex and frontal pole all increased under ketamine compared to saline. The insula is well-placed to influence the balance between bottom-up and top-down processing in predictive coding schemes (Chanes and Barret, 2016) , which has been linked to perceptual distortions in
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Notably, the insula and ACC make up the salience network (SAL), a cluster of regions whose connectivity has been shown through effective connectivity analyses to dampen DMN activity and modulate the connectivity between DMN and DAN/FPN in healthy participants (Chen et al, 2013; Zhou et al, 2018) , which have both been shown previously to be disrupted under ketamine during similar WM tasks . This motivated us to follow-up with explicit tests of the relationship between the salience network and DMN, DAN and FPN, which revealed an effect of ketamine on connectivity between salience network and regions of both the DMN and FPN. Interestingly, hypo-connectivity between the DMN and SAL has been consistently shown in patients with schizophrenia compared to controls (Manoliu et al, 2014;  reviewed in Nekovarova et al, 2014) , while our analyses revealed hyper-connectivity amongst these regions. This difference from the effects we found under ketamine could be related to illness course. Previous research has shown ketamine models functional connectivity in first-episode participants better than in chronic patients, and these two patient groups can show opposite patterns of connectivity within the same region (Anticevic et al, 2015a) . Youth at risk of psychosis do show decreased anti-correlation between DMN and SAL, which is consistent with our current results under ketamine (Wotruba et al, 2014; see 
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Although our dose of ketamine during rest did not induce significant changes in the DMN-DAN/FPN connectivity, we do see changes in connectivity between these large-scale networks and many regions believed to control the anti-correlation between them (insula, ACC) (Di and Biswal, 2014; Chen et al, 2013; Zhou et al, 2018) ; a task condition or higher dose of ketamine (Bonhomme et al, 2016) may be necessary to elicit disrupted anticorrelations between these networks.
Mueller and colleagues (2018) previously found altered connectivity within-subjects under ketamine versus saline between the DLPFC and ACC, superior frontal gyrus and calcarine fissure, which we did not observe with our higher ketamine dose. We did find a relationship between DLPFC-ACC connectivity and mood symptoms so this may be relevant to this change observed While the POMS is a crude measure of mood, these relationships could be relevant to the psychotomimetic and potential antidepressant effects of ketamine. This fits well with previous ideas about the role of the prefrontal cortex connectivity in mood disorders and in ketamine's ability to alleviate these symptoms (Abdallah et al, 2015) . The ACC has also been strongly
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A C C E P T E D M A N U S C R I P T implicated in mood disorders previously (reviewed in Devets et al, 2008) and in ketamine's (and other NMDA antagonists that do not induce psychotic symptoms) early sites of action for its antidepressant effects (Downy et al, 2016) . Further work is needed to explicitly explore these diverging pathways that may be involved in ketamine's effect on mood versus psychosis.
Ketamine has been shown to alter blood flow to the thalamus in a way that correlates with perceptual alterations induced by this drug (Pollak et al, 2015) , but to our knowledge nobody has ever looked at specific patterns of thalamic nuclei connectivity in relation to these symptoms. Our results showed various changes in connectivity with MD thalamus. Changes in several structural and synaptic measures have been discovered specifically in the MD nucleus of the thalamus in schizophrenia (reviewed in Pergola et al, 2015) , while the LGN may be more involved in negative mood symptoms (Dorph-Petersen et al, 2008; reviewed in Leivada and Boeckx, 2014) , so it is not surprising that ketamine elicited altered functional dynamics in the MD thalamus as opposed to
LGN. And this demonstrates that the functional effects of ketamine are specific to certain subregions of the thalamus as opposed to the entire structure. Prior studies demonstrate that patients with schizophrenia have deficits in thalamic connectivity with association cortices, and hyperconnectivity with sensorimotor and sensory cortices (Anticevic et al, 2014a; Anticevic et al, 2014b; Anticevic et al, 2015b) . Our data indicates somewhat different but overlapping patterns of altered thalamic connectivity with ketamine. We found increased mediodorsal thalamic functional connectivity with areas involved in auditory processing in the superior temporal gyrus (in line with previous work), and with parahippocampal gyrus, but no altered connectivity between the
LGN and sensorimotor cortices. We also did not find MD thalamus to PFC changes as seen in patients with schizophrenia (Anticevic et al, 2014a; Anticevic et al, 2014b; Anticevic et al, 2015b ; see table 4 see table 4 for a summary of these results across disease progression in relation
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Finally, we tested for symptom correlations with positive symptom and mood scales, and did not find any significant relationships between our measures of connectivity in the a priori ROIs and positive symptoms of schizophrenia. This is in line with previous research (Mueller et al, 2018) showing ketamine changes relevant to large-scale task positive and default mode network dynamics do not correlate with positive symptoms. It is possible the changes across drug conditions we observed are more relevant to cognitive and working memory deficits, which were not tested in the present study. 
Limitations
There are a few limitations that should be noted when interpreting the results of this study.
First, the design was a between-subjects design with a baseline scan, which may be less powerful than a within-subjects design with a placebo and ketamine scan. This could have driven some of the differences between the present results and previous studies (Mueller et al, 2018) . Second, although the multi-site nature of the study is useful for showing effects of ketamine that are reliable across scanning location, we did see some differences across sites especially related to
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Next, there has been little evidence for the stability of reported CADSS, POMS and BPRS scores following ketamine administration. One study does suggest the CADSS scale has high sensitivity for ketamine's effects but low Interclass Correlations across infusions within-subject (De Simoni et al, 2013) . CADSS scores may not be stable with ketamine infusion, however most of our symptom correlations occur with both BPRS and CADSS subscales with overlapping symptoms measured, suggesting the scales are producing a consistent measure of the participant's experience in our study.
Conclusions
We sought to investigate the effects of ketamine on functional connectivity using seeds of interest previously identified in patients with schizophrenia. We did find alterations consistent with those observed in patients with schizophrenia, including hyper-connectivity between MD thalamus and sensory cortical regions, as well as increased intra-network connectivity within the DMN. We also provide further support that ketamine may model some fc patterns of early or atrisk patients with psychotic illnesses better than chronic schizophrenia patients (Anticevic et al, 2015a) . We provide a table comparing the results we saw under ketamine with previous results reported in patients with schizophrenia across different stages of illness progression (Table 4) .
Unsurprisingly, ketamine does not replicate all of the findings from patients with schizophrenia, including altered large-scale network dynamics at rest and thalamic-PFC connectivity.
Importantly our results identify possible causal relationships between NMDA signaling disruptions and various alterations in patterns of DMN, thalamic, superior temporal cortical and insular connectivity, which have also been observed in patients with schizophrenia. These 
ACCEPTED MANUSCRIPT
